Bavarian Nordic A/S (BVNRY)
8.26
-0.68
(-7.66%)
USD |
OTCM |
Jun 28, 16:00
Bavarian Nordic Enterprise Value: 1.762B for June 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 27, 2024 | 1.762B |
| June 26, 2024 | 1.715B |
| June 25, 2024 | 1.385B |
| June 24, 2024 | 1.411B |
| June 21, 2024 | 1.390B |
| June 20, 2024 | 1.441B |
| June 18, 2024 | 1.441B |
| June 17, 2024 | 1.436B |
| June 14, 2024 | 1.471B |
| June 13, 2024 | 1.525B |
| June 12, 2024 | 1.602B |
| June 11, 2024 | 1.598B |
| June 10, 2024 | 1.663B |
| June 07, 2024 | 1.698B |
| June 06, 2024 | 1.761B |
| June 05, 2024 | 1.773B |
| June 04, 2024 | 1.733B |
| June 03, 2024 | 1.757B |
| May 31, 2024 | 1.759B |
| May 30, 2024 | 1.666B |
| May 29, 2024 | 1.643B |
| May 28, 2024 | 1.663B |
| May 24, 2024 | 1.695B |
| May 23, 2024 | 1.663B |
| May 22, 2024 | 1.677B |
| Date | Value |
|---|---|
| May 21, 2024 | 1.626B |
| May 20, 2024 | 1.676B |
| May 17, 2024 | 1.693B |
| May 16, 2024 | 1.629B |
| May 15, 2024 | 1.604B |
| May 14, 2024 | 1.551B |
| May 13, 2024 | 1.527B |
| May 10, 2024 | 1.477B |
| May 09, 2024 | 1.463B |
| May 08, 2024 | 1.488B |
| May 07, 2024 | 1.481B |
| May 06, 2024 | 1.467B |
| May 03, 2024 | 1.413B |
| May 02, 2024 | 1.357B |
| May 01, 2024 | 1.357B |
| April 30, 2024 | 1.365B |
| April 29, 2024 | 1.366B |
| April 26, 2024 | 1.318B |
| April 25, 2024 | 1.289B |
| April 24, 2024 | 1.343B |
| April 23, 2024 | 1.343B |
| April 22, 2024 | 1.333B |
| April 19, 2024 | 1.297B |
| April 18, 2024 | 1.289B |
| April 17, 2024 | 1.316B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
613.44M
Minimum
Apr 01 2020
3.777B
Maximum
Aug 04 2022
1.756B
Average
1.671B
Median
Enterprise Value Benchmarks
| Genmab A/S | 12.00B |
| Ascendis Pharma A/S | 8.110B |
| Galecto Inc | -13.54M |
| Evaxion Biotech AS | 3.958M |
| IO Biotech Inc | -40.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.67M |
| Revenue (Quarterly) | 121.11M |
| Total Expenses (Quarterly) | 139.88M |
| EPS Diluted (Quarterly) | -0.0728 |
| Gross Profit Margin (Quarterly) | 31.90% |
| Profit Margin (Quarterly) | -13.76% |
| Earnings Yield | 7.53% |
| Operating Earnings Yield | 7.64% |
| Normalized Earnings Yield | 7.461 |